In a recent article published by OncLive, Amy Valley, PharmD, Vice President, Product and Solutions Marketing, Cardinal Health Specialty Solutions, explores some of the ways community-based oncologists are addressing the impact of the COVID-19 pandemic on their practices.
Cardinal Health Specialty Solutions is excited to launch our Practice Research Network (PRN), a new opportunity for community oncology practices.
While this year’s ASCO meeting was virtual, it still featured many promising abstracts across multiple disease states, bringing forth exciting treatment options and practice-changing implications. Clinical experts from Cardinal Health Specialty Solutions summarized the most impactful findings for your practice here.
Experts from Cardinal Health Specialty Solutions have published five examples of RWE being submitted in support of the FDA approvals of original or supplementary indications for oncology drugs.
In this biosimilars update, Cardinal Health’s Vice President of Biosimilars, Sonia Oskouei, PharmD, shares new data indicating that biosimilar uptake is beginning to increase among oncologists and discusses the barriers that continue to affect widespread adoption.
Mounting clinical evidence shows social determinants of health (SDOH) are equally, if not more important to driving health outcomes than a patient’s genetics. In the latest edition of Oncology Insights, oncologists nationwide shared their perspectives on the impact of SDOH on their patients and how they are managing these factors in their practice.